In the Types dimension of Brain Reading Robots segmentation, three core architectures dominate: invasive, non‑invasive, and hybrid systems. Invasive robots integrate microelectrode arrays directly into cortical tissue, delivering unparalleled signal fidelity for clinical interventions but incurring higher regulatory barriers and capital costs, thus occupying a smaller, high‑value niche. Non‑invasive robots rely on external sensing modalities—such as EEG, fNIRS, and MEG—offering broader market accessibility and faster adoption cycles; they dominate the market share due to lower procedural risk and compatibility with outpatient settings. Hybrid robots combine elements of both approaches, using minimally penetrative sensors coupled with advanced AI‑driven signal processing to balance resolution and safety, emerging as a growth catalyst in research institutions seeking scalable yet precise data. Each type contributes distinct cost structures, adoption timelines, and revenue potentials, collectively informing the market taxonomy and guiding strategic investment across the Brain Reading Robots landscape.